Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke
NCT ID: NCT05525949
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2022-10-19
2023-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Perceptual Learning for the Treatment of Visual Field Defect
NCT01959256
ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease
NCT01772693
Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease
NCT06052930
Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery
NCT05220449
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
NCT05400499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VIVID Brain
VIVID Brain, 5 times a week for 12 weeks
VIVID Brain
Participants receive visual perceptual training using the VIVID Brain software.
No-treatment Control
No-treatment is administered during control period.
No-treatment Control
No-treatment is administered during control period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIVID Brain
Participants receive visual perceptual training using the VIVID Brain software.
No-treatment Control
No-treatment is administered during control period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 3 months after brain disease related to visual field defect
* Verified brain disease in visual pathway related to occipital lobe, parietal lobe, temporal lobe or etc. using CT or MRI
* Brain disease induced visual field defect
* Able to use the VR(Virtual Reality) device
* Able to use the app with a smart phone
* Patient/legally authorized representative has signed the informed consent form
Exclusion Criteria
* Epilepsy, photosensitivity, Parkinson's disease
* Bilateral visual field defect
* Hemispatial neglect
* Ophthalmologic disorder that may interfere the trial. (Ptosis of Eyelid, Corneal Opacity, Diabetic Retinopathy, Glaucoma, Macular Degeneration etc.)
* Inability to discontinue psychostimulants such as methylphenidate, modafinil, and amphetamine.
* Candidate for carotid endarterectomy or stenting
* Received ophthalmologic surgery or laser surgery within 3 months, except for the cataract surgery
* Pregnant or breast feeding
* Participating in other clinical trial
* Any other condition that, in the opinion of the investigator, precludes participation in the trial
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nunaps Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gyeong-Moon Kim, MD, PhD
Role: STUDY_CHAIR
Samsung Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korea University Ansan Hospital
Ansan, , South Korea
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Daejeon Eulji University Medical Center
Daejeon, , South Korea
Inje University Ilsan Paik Hospital
Goyang, , South Korea
Seoul National University Bundang Hospital
Seongnam, , South Korea
Asan Medical Center
Seoul, , South Korea
Chung-Ang University Hospital
Seoul, , South Korea
Konkuk University Hospital
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, , South Korea
The Catholic University of Korea Yeouido St. Mary's Hospital
Seoul, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Namgung E, Kim BJ, Kwon JH, Han MK, Kim HY, Jung JM, Kim JG, Park KY, Koo J, Hong KS, Yu KH, Cho AH, Chang JY, Kwon SU, Lee BJ, Choi HG, Cho M, Kim GM, Kang DW. Personalized Visual Perceptual Learning Digital Therapy for Visual Field Defects Following Stroke: A Randomized Clinical Trial. JAMA Netw Open. 2025 May 1;8(5):e2511068. doi: 10.1001/jamanetworkopen.2025.11068.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NNS-VB-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.